Bayer Wins Major Legal Battle Over Roundup Cancer Claims

U.S. appeals court rules in favor of Bayer, boosting share prices and potentially setting the stage for Supreme Court involvement.

Bayer's stock surged over 11% after the favorable ruling by the 3rd U.S. Circuit Court of Appeals.
The court decision overturned a previous verdict requiring cancer warnings on Roundup labels under Pennsylvania law.
The ruling cited federal law, which mandates uniform labeling and does not require a cancer warning for Roundup.
Bayer has faced extensive litigation and has paid nearly $11 billion to settle similar cases, with many still unresolved.
The company is lobbying Congress for legislative protection against future lawsuits related to glyphosate.